Single arm:SNUG01
Sponsors
Peking University Third Hospital, Xingtai People's Hospital
Conditions
Amyotrophic lateral sclerosis
Early Phase 1
A single-arm, open exploratory clinical study evaluating a single intrathecal injection of SNUG01 in patients with amyotrophic lateral sclerosis
RecruitingChiCTR2300076019
Start: 2023-09-22Updated: 2023-09-26
A single-arm, open exploratory clinical study evaluating a single intrathecal injection of SNUG01 in patients with amyotrophic lateral sclerosis (Compassionate use)
Active, not recruitingChiCTR2400085764
Start: 2023-04-24Updated: 2024-07-08
A Multicenter, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal of SNUG01 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Active, not recruitingChiCTR2400090090
Start: 2024-09-30Updated: 2024-09-30